Vaccines
- Taylor K, Nguyen A, Stephenne J. (2009) The need for new vaccines.Vaccine>; 275:G3-G8.
- Brown G, VS Moorthy VS, Z Reed, K Mendis, M Arevalo-Herera, P Alonso. Priorities in research and development of vaccines against Plasmodium viviax malaria, Vaccine, 2009; 27:7228-7235
- Mueller I, Moorthy VS, Brown GV, Smith PG, Alonso P, Genton B. Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection, Vaccine 2009; 27:5633-5643
- Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, Campbell DA. (2007) Pneumococcal polysaccharide vaccine may not prevent hospitalization for pneumonia in elderly individuals. Clin Infect Dis 44:617.
- Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, Campbell DA. (2007) Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated. Vaccine 25: 4631-4640.
- Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, Campbell DA. (2007) Missed opportunities to vaccinate a cohort of hospitalised elderly with pneumococcal and influenza vaccines. Vaccine 25:5146-5154.
- Skull SA, Andrews RM, Byrnes GB, Campbell DA, Nolan TM, Brown GV, Kelly HA. (2007) ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged >=65 years. Epidemiol Infect (online 20 April 2007).
- Kermode M, Yong K, Hurley S, Marmion B. An economic evaluation of increased uptake in Q fever vaccination amongst meat and agricultural industry workers following implementation of the National Q Fever Management Program. Australia and New Zealand Journal of Public Health 2003: 27(4) 390-398
- Harris A, Yong K, Kermode M. 2001. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine: A decision analytic approach to cost effectiveness. Australian and New Zealand Journal of Public Health; 25(3): 222-229